DJIA 17,161.66 130.52 0.77%
NASDAQ 4,553.58 34.68 0.77%
S&P 500 2,001.70 17.57 0.89%
market minute promo

Alnylam Pharmaceuticals (NASDAQ: ALNY)

72.16 0.21 (0.29%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALNY $72.16 0.29%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $71.80
Previous Close $71.95
Daily Range $70.55 - $73.52
52-Week Range $47.03 - $112.57
Market Cap $5.5B
P/E Ratio -14.08
Dividend (Yield) $0.00 (0.0%)
Volume 462,551
Average Daily Volume 544,561
Current FY EPS -$5.37

Sector

Healthcare

Industry

Drugs

Alnylam Pharmaceuticals (ALNY) Description

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes. Website: http://www.alnylam.com/

News & Commentary Rss Feed

Growth and Dividends: Europe's Best Pharma Stock

Read below to find out which stock it is.

Alnylam Expands Pipeline with Preeclampsia Drug ALN-AGT - Analyst Blog

Tekmira: Much More Than An Ebola Treatment

Alnylam Broadens Pipeline With ALN-AGT, A Subcutaneously Administered RNAi Therapeutic Targeting Ang

Alnylam Broadens Pipeline With ALN-AGT, A Subcutaneously Administered RNAi Therapeutic Targeting Angiotensinogen For The Treatment Of Hypertensive Disorders Of Pregnancy, Including Preeclampsia

ALNY Makes Notable Cross Below Critical Moving Average

Gilead: Let's Make A Deal

Alnylam Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for ALNY

Alnylam's Q2 Loss Wider-than-Expected, Pipeline in Focus - Analyst Blog

New Analyst Biotech Stocks to Buy With Gigantic Implied Upside

Alnylam Pharmaceuticals Has Plenty On Its Plate

Alnylam Pharmaceuticals' (ALNY) CEO John Maraganore on Q2 2014 Results - Earnings Call Transcript

See More ALNY News...

ALNY's Top Competitors

ALNY $72.16 (0.29%)
Current stock: ALNY
AMGN $138.97 (0.72%)
Current stock: AMGN
GILD $104.14 (3.12%)
Current stock: GILD
BIIB $327.38 (2.27%)
Current stock: BIIB